Hepatitis E: Clinical presentation in disease-endemic areas and diagnosis

Seminars in Liver Disease

Volumn 33, Issue 1, 2013, Pages 30-40

  Aggarwal, Rakesh A ^a  

^a SANJAY GANDHI POSTGRADUATE INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

anti HEV antibodies; clinical manifestations; diagnosis; hepatitis E; HEV; immunoassays

Indexed keywords

HEPATITIS E ANTIBODY; IMMUNOGLOBULIN M ANTIBODY; VIRUS RNA;

ANTIBODY DETECTION; ARTICLE; CLINICAL FEATURE; DISEASE ASSOCIATION; DISEASE SEVERITY; ENDEMIC DISEASE; ENZYME IMMUNOASSAY; GENOTYPE; HEPATITIS E; HEPATITIS E VIRUS; HUMAN; INFECTION RISK; LABORATORY DIAGNOSIS; MORTALITY; PREGNANT WOMAN; PRIORITY JOURNAL; SEROPREVALENCE;

ADULT; CHILD; ENDEMIC DISEASES; FEMALE; HEPATITIS E; HUMANS; INFANT, NEWBORN; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS;

EID: 84876007420     PISSN: 02728087     EISSN: 10988971     Source Type: Journal    
DOI: 10.1055/s-0033-1338112     Document Type: Article

References (87)

1. Ahmad I., Holla R. P., Jameel S. Molecular virology of hepatitis E virus. Virus Res: 2011; 161 1 47 58
2. Mori Y., Matsuura Y. Structure of hepatitis E viral particle. Virus Res: 2011; 161 1 59 64
3. Lu L., Li C., Hagedorn C. H. Phylogenetic analysis of global hepatitis E virus sequences: genetic diversity, subtypes and zoonosis. Rev Med Virol: 2006; 16 1 5 36
4. Purdy M. A., Khudyakov Y. E. The molecular epidemiology of hepatitis E virus infection. Virus Res: 2011; 161 1 31 39
5. Khuroo M. S. Study of an epidemic of non-A, non-B hepatitis. Possibility of another human hepatitis virus distinct from post-transfusion non-A, non-B type. Am J Med: 1980; 68 6 818 824
6. Aggarwal R. Hepatitis E: Historical, contemporary and future perspectives. J Gastroenterol Hepatol: 2011; 26 01 72 82
7. Aggarwal R., Naik S. Epidemiology of hepatitis E: current status. J Gastroenterol Hepatol: 2009; 24 9 1484 1493
8. Dalton H. R., Bendall R., Ijaz S., Banks M. Hepatitis E: an emerging infection in developed countries. Lancet Infect Dis: 2008; 8 11 698 709
9. Kamar N., Garrouste C., Haagsma E. B., et al. Factors associated with chronic hepatitis in patients with hepatitis E virus infection who have received solid organ transplants. Gastroenterology: 2011; 140 5 1481 1489
10. Aggarwal R. Clinical presentation of hepatitis E. Virus Res: 2011; 161 1 15 22
11. Viswanathan R., Sidhu A. S. Infectious hepatitis; clinical findings. Indian J Med Res: 1957; 45 (Suppl.): 49 58
12. Morrow R. H. Jr, Smetana H. F., Sai F. T., Edgcomb J. H. Unusual features of viral hepatitis in Accra, Ghana. Ann Intern Med: 1968; 68 6 1250 1264
13. Zhuang H., Cao X-Y, Liu C-B, Wang G-M. Enterically transmitted non-A, non-B hepatitis in China. In: Shikata T., Purcell R. H., Uchida T., eds. Viral Hepatitis C, D and E. Amsterdam Excerpta Medica: 1991; 277-285
14. Tsega E., Krawczynski K., Hansson B. G., et al. Outbreak of acute hepatitis E virus infection among military personnel in northern Ethiopia. J Med Virol: 1991; 34 4 232 236
15. Khuroo M. S., Duermeyer W., Zargar S. A., Ahanger M. A., Shah M. A. Acute sporadic non-A, non-B hepatitis in India. Am J Epidemiol: 1983; 118 3 360 364
16. Balayan M. S., Andjaparidze A. G., Savinskaya S. S., et al. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology: 1983; 20 1 23 31
17. Chauhan A., Jameel S., Dilawari J. B., Chawla Y. K., Kaur U., Ganguly N. K. Hepatitis E virus transmission to a volunteer. Lancet: 1993; 341 8838 149 150
18. Viswanathan R. Epidemiology. Indian J Med Res: 1957; 45 (Suppl.): 1 29
19. Chuttani H. K., Sidhu A. S., Wig K. L., Gupta D. N., Ramalingaswami V. Follow-up study of cases from the Delhi epidemic of infectious hepatitis of 1955-6. Br Med J: 1966; 2 5515 676 679
20. Khuroo M. S., Saleem M., Teli M. R., Sofi M. A. Failure to detect chronic liver disease after epidemic non-A, non-B hepatitis. Lancet: 1980; 2 8185 97 98
21. Nanda S. K., Yalcinkaya K., Panigrahi A. K., Acharya S. K., Jameel S., Panda S. K. Etiological role of hepatitis E virus in sporadic fulminant hepatitis. J Med Virol: 1994; 42 2 133 137
22. Chadha M. S., Walimbe A. M., Chobe L. P., Arankalle V. A. Comparison of etiology of sporadic acute and fulminant viral hepatitis in hospitalized patients in Pune, India during 1978-81 and 1994-97. Indian J Gastroenterol: 2003; 22 1 11 15
23. Acharya S. K., Dasarathy S., Kumer T. L., et al. Fulminant hepatitis in a tropical population: clinical course, cause, and early predictors of outcome. Hepatology: 1996; 23 6 1448 1455
24. Ramachandran J., Ramakrishna B., Eapen C. E., et al. Subacute hepatic failure due to hepatitis E. J Gastroenterol Hepatol: 2008; 23 6 879 882
25. Naik S. R., Aggarwal R., Salunke P. N., Mehrotra N. N. A large waterborne viral hepatitis E epidemic in Kanpur, India. Bull World Health Organ: 1992; 70 5 597 604
26. Wahi P. N., Arora M. M. Epidemic hepatitis. N Engl J Med: 1952; 248 11 451 454
27. Khuroo M. S., Teli M. R., Skidmore S., Sofi M. A., Khuroo M. I. Incidence and severity of viral hepatitis in pregnancy. Am J Med: 1981; 70 2 252 255
28. Bhatia V., Singhal A., Panda S. K., Acharya S. K. A 20-year single-center experience with acute liver failure during pregnancy: is the prognosis really worse? Hepatology: 2008; 48 5 1577 1585
29. Stoszek S. K., Abdel-Hamid M., Saleh D. A., et al. High prevalence of hepatitis E antibodies in pregnant Egyptian women. Trans R Soc Trop Med Hyg: 2006; 100 2 95 101
30. Hamid S. S., Atiq M., Shehzad F., et al. Hepatitis E virus superinfection in patients with chronic liver disease. Hepatology: 2002; 36 2 474 478
31. Kumar A., Aggarwal R., Naik S. R., Saraswat V., Ghoshal U. C., Naik S. Hepatitis E virus is responsible for decompensation of chronic liver disease in an endemic region. Indian J Gastroenterol: 2004; 23 2 59 62
32. Monga R., Garg S., Tyagi P., Kumar N. Superimposed acute hepatitis E infection in patients with chronic liver disease. Indian J Gastroenterol: 2004; 23 2 50 52
33. Ramachandran J., Eapen C. E., Kang G., et al. Hepatitis E superinfection produces severe decompensation in patients with chronic liver disease. J Gastroenterol Hepatol: 2004; 19 2 134 138
34. Radha Krishna Y., Saraswat V. A., Das K., et al. Clinical features and predictors of outcome in acute hepatitis A and hepatitis E virus hepatitis on cirrhosis. Liver Int: 2009; 29 3 392 398
35. Jagadisan B., Srivastava A., Yachha S. K., Poddar U. Acute on chronic liver disease in children from the developing world: recognition and prognosis. J Pediatr Gastroenterol Nutr: 2012; 54 1 77 82
36. Kumar Acharya S., Kumar Sharma P., Singh R., et al. Hepatitis E virus (HEV) infection in patients with cirrhosis is associated with rapid decompensation and death. J Hepatol: 2007; 46 3 387 394
37. Khuroo M. S., Kamili S., Jameel S. Vertical transmission of hepatitis E virus. Lancet: 1995; 345 8956 1025 1026
38. Khuroo M. S., Kamili S., Khuroo M. S. Clinical course and duration of viremia in vertically transmitted hepatitis E virus (HEV) infection in babies born to HEV-infected mothers. J Viral Hepat: 2009; 16 7 519 523
39. Kamar N., Selves J., Mansuy J. M., et al. Hepatitis E virus and chronic hepatitis in organ-transplant recipients. N Engl J Med: 2008; 358 8 811 817
40. Naik A., Gupta N., Goel D., Ippagunta S. K., Sharma R. K., Aggarwal R. Lack of evidence of hepatitis E virus infection among renal transplant recipients in a disease-endemic area [published online ahead of print November 26, 2012]. J Viral Hepat. doi: 10.1111/jvh.12027
41. Thapa R., Mallick D., Ghosh A. Childhood hepatitis E infection complicated by acute immune thrombocytopenia. J Pediatr Hematol Oncol: 2009; 31 2 151
42. Abid S., Khan A. H. Severe hemolysis and renal failure in glucose-6-phosphate dehydrogenase deficient patients with hepatitis E. Am J Gastroenterol: 2002; 97 6 1544 1547
43. Ali G., Kumar M., Bali S. K., Wadhwa W. B. Hepatitis E associated immune thrombocytopenia and membranous glomerulonephritis. Indian J Nephrol: 2001; 11 70 72
44. Thapa R., Biswas B., Mallick D. Henoch-Schönlein purpura triggered by acute hepatitis E virus infection. J Emerg Med: 2010; 39 2 218 219
45. Bhagat S., Wadhawan M., Sud R., Arora A. Hepatitis viruses causing pancreatitis and hepatitis: a case series and review of literature. Pancreas: 2008; 36 4 424 427
46. Cheung M. C., Maguire J., Carey I., Wendon J., Agarwal K. Review of the neurological manifestations of hepatitis E infection. Ann Hepatol: 2012; 11 5 618 622
47. Kamar N., Izopet J., Cintas P., et al. Hepatitis E virus-induced neurological symptoms in a kidney-transplant patient with chronic hepatitis. Am J Transplant: 2010; 10 5 1321 1324
48. Aggarwal R. Diagnosis of hepatitis E. Nat Rev Gastroenterol Hepatol: 2013; 10 1 24 33
49. Krawczynski K., Meng X. J., Rybczynska J. Pathogenetic elements of hepatitis E and animal models of HEV infection. Virus Res: 2011; 161 1 78 83
50. Khuroo M. S., Kamili S., Dar M. Y., Moecklii R., Jameel S. Hepatitis E and long-term antibody status. Lancet: 1993; 341 8856 1355
51. Myint K. S., Endy T. P., Shrestha M. P., et al. Hepatitis E antibody kinetics in Nepalese patients. Trans R Soc Trop Med Hyg: 2006; 100 10 938 941
52. Baylis S. A., Hanschmann K. M., Blümel J., Nübling C. M. HEV Collaborative Study Group Standardization of hepatitis E virus (HEV) nucleic acid amplification technique-based assays: an initial study to evaluate a panel of HEV strains and investigate laboratory performance. J Clin Microbiol: 2011; 49 4 1234 1239
53. Lan X., Yang B., Li B. Y., Yin X. P., Li X. R., Liu J. X. Reverse transcription-loop-mediated isothermal amplification assay for rapid detection of hepatitis E virus. J Clin Microbiol: 2009; 47 7 2304 2306
54. Bradley D. W., Krawczynski K., Cook E. H. Jr., et al. Enterically transmitted non-A, non-B hepatitis: serial passage of disease in cynomolgus macaques and tamarins and recovery of disease-associated 27- to 34-nm viruslike particles. Proc Natl Acad Sci U S A: 1987; 84 17 6277 6281
55. Zhang F., Li X., Li Z., et al. Detection of HEV antigen as a novel marker for the diagnosis of hepatitis E. J Med Virol: 2006; 78 11 1441 1448
56. Krawczynski K., Bradley D. W. Enterically transmitted non-A, non-B hepatitis: identification of virus-associated antigen in experimentally infected cynomolgus macaques. J Infect Dis: 1989; 159 6 1042 1049
57. Herremans M., Duizer E., Jusic E., Koopmans M. P. Detection of hepatitis E virus-specific immunoglobulin A in patients infected with hepatitis E virus genotype 1 or 3. Clin Vaccine Immunol: 2007; 14 3 276 280
58. Takahashi M., Kusakai S., Mizuo H., et al. Simultaneous detection of immunoglobulin A (IgA) and IgM antibodies against hepatitis E virus (HEV) is highly specific for diagnosis of acute HEV infection. J Clin Microbiol: 2005; 43 1 49 56
59. Zhang J., Gu Y., Ge S. X., et al. Analysis of hepatitis E virus neutralization sites using monoclonal antibodies directed against a virus capsid protein. Vaccine: 2005; 23 22 2881 2892
60. Emerson S. U., Clemente-Casares P., Moiduddin N., Arankalle V. A., Torian U., Purcell R. H. Putative neutralization epitopes and broad cross-genotype neutralization of Hepatitis E virus confirmed by a quantitative cell-culture assay. J Gen Virol: 2006; 87 Pt 3 697 704
61. Li F., Riddell M. A., Seow H. F., Takeda N., Miyamura T., Anderson D. A. Recombinant subunit ORF2.1 antigen and induction of antibody against immunodominant epitopes in the hepatitis E virus capsid protein. J Med Virol: 2000; 60 4 379 386
62. Zhang J. Z., Ng M. H., Xia N. S., et al. Conformational antigenic determinants generated by interactions between a bacterially expressed recombinant peptide of the hepatitis E virus structural protein. J Med Virol: 2001; 64 2 125 132
63. Robinson R. A., Burgess W. H., Emerson S. U., et al. Structural characterization of recombinant hepatitis E virus ORF2 proteins in baculovirus-infected insect cells. Protein Expr Purif: 1998; 12 1 75 84
64. Tsarev S. A., Tsareva T. S., Emerson S. U., et al. ELISA for antibody to hepatitis E virus (HEV) based on complete open-reading frame-2 protein expressed in insect cells: identification of HEV infection in primates. J Infect Dis: 1993; 168 2 369 378
65. Zhang M., Emerson S. U., Nguyen H., et al. Immunogenicity and protective efficacy of a vaccine prepared from 53 kDa truncated hepatitis E virus capsid protein expressed in insect cells. Vaccine: 2001; 20 5-6 853 857
66. Jameel S., Zafrullah M., Ozdener M. H., Panda S. K. Expression in animal cells and characterization of the hepatitis E virus structural proteins. J Virol: 1996; 70 1 207 216
67. Ma Y., Lin S. Q., Gao Y., et al. Expression of ORF2 partial gene of hepatitis E virus in tomatoes and immunoactivity of expression products. World J Gastroenterol: 2003; 9 10 2211 2215
68. Zhou Y. X., Lee M. Y., Ng J. M., et al. A truncated hepatitis E virus ORF2 protein expressed in tobacco plastids is immunogenic in mice. World J Gastroenterol: 2006; 12 2 306 312
69. Sehgal D., Malik P. S., Jameel S. Purification and diagnostic utility of a recombinant hepatitis E virus capsid protein expressed in insect larvae. Protein Expr Purif: 2003; 27 1 27 34
70. Jiménez de Oya N., Galindo I., Gironés O., Duizer E., Escribano J. M., Saiz J. C. Serological immunoassay for detection of hepatitis E virus on the basis of genotype 3 open reading frame 2 recombinant proteins produced in Trichoplusia ni larvae. J Clin Microbiol: 2009; 47 10 3276 3282
71. Khudyakov Y. E., Favorov M. O., Khudyakova N. S., et al. Artificial mosaic protein containing antigenic epitopes of hepatitis E virus. J Virol: 1994; 68 11 7067 7074
72. Ulanova T. I., Obriadina A. P., Talekar G., Burkov A. N., Fields H. A., Khudyakov Y. E. A new artificial antigen of the hepatitis E virus. J Immunoassay Immunochem: 2009; 30 1 18 39
73. Riddell M. A., Li F., Anderson D. A. Identification of immunodominant and conformational epitopes in the capsid protein of hepatitis E virus by using monoclonal antibodies. J Virol: 2000; 74 17 8011 8017
74. Khudyakov Y., Kamili S. Serological diagnostics of hepatitis E virus infection. Virus Res: 2011; 161 1 84 92
75. Herremans M., Bakker J., Duizer E., Vennema H., Koopmans M. P. Use of serological assays for diagnosis of hepatitis E virus genotype 1 and 3 infections in a setting of low endemicity. Clin Vaccine Immunol: 2007; 14 5 562 568
76. Yu C., Engle R. E., Bryan J. P., Emerson S. U., Purcell R. H. Detection of immunoglobulin M antibodies to hepatitis E virus by class capture enzyme immunoassay. Clin Diagn Lab Immunol: 2003; 10 4 579 586
77. Chen H. Y., Lu Y., Howard T., et al. Comparison of a new immunochromatographic test to enzyme-linked immunosorbent assay for rapid detection of immunoglobulin m antibodies to hepatitis e virus in human sera. Clin Diagn Lab Immunol: 2005; 12 5 593 598
78. Myint K. S., Guan M., Chen H. Y., et al. Evaluation of a new rapid immunochromatographic assay for serodiagnosis of acute hepatitis E infection. Am J Trop Med Hyg: 2005; 73 5 942 946
79. Legrand-Abravanel F., Thevenet I., Mansuy J. M., et al. Good performance of immunoglobulin M assays in diagnosing genotype 3 hepatitis E virus infections. Clin Vaccine Immunol: 2009; 16 5 772 774
80. Hu W. P., Lu Y., Precioso N. A., et al. Double-antigen enzyme-linked immunosorbent assay for detection of hepatitis E virus-specific antibodies in human or swine sera. Clin Vaccine Immunol: 2008; 15 8 1151 1157
81. Dong C., Meng J., Dai X., et al. Restricted enzooticity of hepatitis E virus genotypes 1 to 4 in the United States. J Clin Microbiol: 2011; 49 12 4164 4172
82. Bendall R., Ellis V., Ijaz S., Ali R., Dalton H. A comparison of two commercially available anti-HEV IgG kits and a re-evaluation of anti-HEV IgG seroprevalence data in developed countries. J Med Virol: 2010; 82 5 799 805
83. Drobeniuc J., Meng J., Reuter G., et al. Serologic assays specific to immunoglobulin M antibodies against hepatitis E virus: pangenotypic evaluation of performances. Clin Infect Dis: 2010; 51 3 e24 e27
84. Mast E. E., Alter M. J., Holland P. V., Purcell R. H. Hepatitis E Virus Antibody Serum Panel Evaluation Group Evaluation of assays for antibody to hepatitis E virus by a serum panel. Hepatology: 1998; 27 3 857 861
85. Loong T. W. Understanding sensitivity and specificity with the right side of the brain. BMJ: 2003; 327 7417 716 719
86. Shata M. T., Barrett A., Shire N. J., et al. Characterization of hepatitis E-specific cell-mediated immune response using IFN-gamma ELISPOT assay. J Immunol Methods: 2007; 328 1-2 152 161
87. Husain M. M., Srivastava R., Akondy R., Aggarwal R., Jameel S., Naik S. Evidence of hepatitis E virus exposure among seronegative healthy residents of an endemic area. Intervirology: 2011; 54 3 139 143